Tweets
IL-6 Inhibitor Safety Issues-Download now!
https://t.co/rjId76sJ64 https://t.co/QwBJNmrzBf
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
In a head to head trial Upadacitinib was superior to Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis. 24wk DBRCT, 924 pts given either UPA 30/d vsDUP 300 EOW. ESI75 response@wk16, UPA 71% vs DUP 61% https://t.co/5cOoosKyao
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
New podcast available for download!
https://t.co/5K8ejJ4jj2 https://t.co/Va66dLGrXO
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
ICYMI:
Skin Involvement with HMGCR Necrotizing Myositis
The Journal of Autoimmunity reports that anti-HMRCR antibody positive, necrotizing myositis patients frequently have cutaneous lesions, more so than previously reported.
https://t.co/RR07dYIJSr https://t.co/MiaIqvMPaB
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
ICYMI:
D-penicillamine Adverse events reported to FDA (1970-2020): dystonia (OR 20.52), drug hypersensitivity (OR 5.42), pancytopenia (OR 10.2), joint swelling (OR 9.07), Renal (OR 6.68), dysphagia (OR 5.05), CHF (OR 4.04), edema (OR: 3.77) https://t.co/8lmYiJo2Tz
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
ICYMI:
CRESS – A New Composite Measure for Primary Sjögren's Syndrome
https://t.co/7tvjBvP3g4
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
ICYMI:
JRheum review: 40–50% of psoriasis pts have psoriatic nail disease NP). NP is an important predictor of enthesitis, which is associated with the early stages of PsA https://t.co/sEuih3CSgX
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
It was a banner week at the FDA; a new drug approval you should know about; a lot of information about pregnancy & safety; and an interesting case plus a question from one of our readers submitted. This and more in this week's podcast. Let's dive in.
https://t.co/5K8ejJ4jj2 https://t.co/pqCsvYuI96
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Veterans study gout prevalence rose from 4.2% to 5.8%, 2005 to 2014. 2014, 4.0% of all inpatient/outpatient encounters & 1.3% of hospitalizations were gout related. ULT use remained stable with 46% of gout patients receiving ULT https://t.co/Lmf2mmMddW
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Skin Involvement with HMGCR Necrotizing Myositis
The Journal of Autoimmunity reports that anti-HMRCR antibody positive, necrotizing myositis patients frequently have cutaneous lesions, more so than previously reported.
https://t.co/RR07dYIJSr https://t.co/f4WdkRZWpM
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Rheumatic Flares Uncommon After COVID Vax
https://t.co/fuyC50K5UF
Post-vaccination disease flares were uncommon among patients with rheumatic and musculoskeletal diseases who were inoculated against COVID-19, researchers found. https://t.co/jp0ZoRqnla
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Study of 708 newly Dx rotator cuff disorder shows that 6 sessions of Progressive exercise was not superior to a 1 physiotherapist session in improving shoulder pain and function. Subacromial corticosteroid injection provided no long-term benefits https://t.co/Flqv286MVV
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
